We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300604:SZSEHangzhou Changchuan Technology Co. Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥125.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hangzhou Changchuan Technology is trading at CNY 125.81, comfortably above its 20‑day SMA of 131.68 and 50‑day SMA of 127.47, yet still close to the identified support at CNY 120.30. The 30‑day volatility of 58% and a near‑neutral RSI of 46.4 suggest the stock is in a relatively wide trading range, while the MACD remains bearish (histogram –1.66), hinting at short‑term downside pressure despite an overall bullish trend direction. Volume is on a decreasing trajectory, which could limit the strength of any breakout.
Fundamentally, the company posts impressive operating margins (36% operating, 20% net) and a robust ROE of 22%, driven by a 60% revenue growth rate. However, valuation metrics are extreme: a trailing PE of 83.3 versus an industry average of 34.2, a price‑to‑book of 18.5, and a DCF‑derived fair value of only CNY 10.6. Debt‑to‑equity stands at 45.5% and free cash flow is negative, raising concerns about cash sustainability. The dividend yield is a modest 0.08% with a low payout ratio, indicating limited dividend resilience.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at CNY 120.30
  • Bullish overall trend but bearish MACD signal
  • Decreasing volume may limit upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong operating margins and 60% revenue growth
  • Extreme valuation multiples (PE 83x, DCF fair value CNY 10.6)
  • Negative free cash flow and elevated debt levels

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term secular demand for semiconductor equipment in 5G and cloud
  • Persistently overvalued pricing relative to fundamentals
  • Regulatory and geopolitical exposure in China

Key Metrics & Analysis

Financial Health

Revenue Growth60.00%
Profit Margin19.78%
P/E Ratio83.3
ROE22.18%
ROA7.34%
Debt/Equity45.51
P/B Ratio18.5
Op. Cash FlowCN¥287.1M
Free Cash FlowCN¥-503456544
Industry P/E34.2

Technical Analysis

TrendBullish
RSI46.4
SupportCN¥120.30
ResistanceCN¥151.10
MA 20CN¥131.68
MA 50CN¥127.47
MA 200CN¥79.15
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥10.63
GradeOvervalued
TypeGrowth
Dividend Yield0.08%

Risk Assessment

Beta0.05
Volatility58.14%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.